Medication info
Carbetalol 12.5 mg Tablet (Carvedilol)

Carbetalol 12.5 mg Tablet (Carvedilol)

Prescription medicationTabletOral
Ingredient · strength
Carvedilol›12.5mg / 1 tablet
Manufacturer / importer
HLB Pharmaceuticals Co., Ltd.
Appearance
Brownish-red round tablet
Packaging
90 tablets (10 tablets/PTP × 9)
Approval status
Active

MFDS item code 201805247 · Approved 2018.12.26 · Insurance code 647303570

Summary

Main use
Adjunctive treatment of congestive heart failure, treatment of essential hypertension, and treatment of chronic stable angina
Who takes it
Adults
Adult dose
Do not increase the dose or stop taking this medicine without your doctor's instructions. 1. Essential hypertension 1) Adults (1) For the first 2 days, administer 12.5 mg of carvedilol orally once daily, then administer 25 mg orally once daily. (2) The usual dose is 25 mg orally once daily for 2 weeks. If a dose increase is needed, increase to 25 mg twice daily. The maximum dose per administration is 25 mg, and the maximum daily dose is 50 mg. 2) Elderly patients In some elderly patients, 12.5 mg once daily may be sufficient to achieve the desired effect. However, the dose may be increased if the effect is insufficient after 2 weeks of treatment. 2. Chronic stable angina 1) For the first 2 days, administer 12.5 mg of this medicine orally twice daily, then administer 25 mg orally twice daily. 2) The usual dose is 25 mg twice daily for 2 weeks. If a dose increase is needed (excluding elderly patients), the dose may be increased up to 50 mg twice daily. 3. Congestive heart failure Before starting treatment with this medicine, the patient's existing standard therapy (conventional treatment for chronic heart failure, typically including an ACE inhibitor, a diuretic, and a digitalis preparation) should be stable. Fluid retention should also be minimized before starting treatment with this medicine. 1) The usual initial dose is 3.125 mg of this medicine orally twice daily for 2 weeks. If the patient tolerates this treatment well, increase the dose to 6.25 mg twice daily for 2 weeks, then increase to 12.5 mg twice daily for 2 weeks, and then increase to 25 mg twice daily. 2) Increase the dose gradually after taking each dose level for at least 2 weeks, up to the dose tolerated by the patient. 3) The minimum effective dose is 6.25 mg twice daily. The maximum dose is 25 mg twice daily for patients weighing 85 kg or less, and 50 mg twice daily for patients weighing more than 85 kg. 4) To control the rate of absorption, it is recommended that this medicine be taken with meals in the morning and evening. Taking it with meals slows the rate of absorption and may reduce the incidence of orthostatic hypotension.

Ingredients

Manufacturer
HLB Pharmaceuticals Co., Ltd.

Efficacy & effects

Adjunctive treatment of congestive heart failure, treatment of essential hypertension, and treatment of chronic stable angina

  • Essential hypertension
  • stable chronic angina
  • congestive heart failure
View approved original text

This medication is used for essential hypertension, stable chronic angina, and congestive heart failure. It is particularly effective as an adjunctive treatment in combination with diuretics, digitalis preparations, ACE inhibitors, and other vasodilators. This helps in controlling blood pressure and improving cardiac function.

How to take

Adult dose

Do not increase the dose or stop taking this medicine without your doctor's instructions. 1. Essential hypertension 1) Adults (1) For the first 2 days, administer 12.5 mg of carvedilol orally once daily, then administer 25 mg orally once daily. (2) The usual dose is 25 mg orally once daily for 2 weeks. If a dose increase is needed, increase to 25 mg twice daily. The maximum dose per administration is 25 mg, and the maximum daily dose is 50 mg. 2) Elderly patients In some elderly patients, 12.5 mg once daily may be sufficient to achieve the desired effect. However, the dose may be increased if the effect is insufficient after 2 weeks of treatment. 2. Chronic stable angina 1) For the first 2 days, administer 12.5 mg of this medicine orally twice daily, then administer 25 mg orally twice daily. 2) The usual dose is 25 mg twice daily for 2 weeks. If a dose increase is needed (excluding elderly patients), the dose may be increased up to 50 mg twice daily. 3. Congestive heart failure Before starting treatment with this medicine, the patient's existing standard therapy (conventional treatment for chronic heart failure, typically including an ACE inhibitor, a diuretic, and a digitalis preparation) should be stable. Fluid retention should also be minimized before starting treatment with this medicine. 1) The usual initial dose is 3.125 mg of this medicine orally twice daily for 2 weeks. If the patient tolerates this treatment well, increase the dose to 6.25 mg twice daily for 2 weeks, then increase to 12.5 mg twice daily for 2 weeks, and then increase to 25 mg twice daily. 2) Increase the dose gradually after taking each dose level for at least 2 weeks, up to the dose tolerated by the patient. 3) The minimum effective dose is 6.25 mg twice daily. The maximum dose is 25 mg twice daily for patients weighing 85 kg or less, and 50 mg twice daily for patients weighing more than 85 kg. 4) To control the rate of absorption, it is recommended that this medicine be taken with meals in the morning and evening. Taking it with meals slows the rate of absorption and may reduce the incidence of orthostatic hypotension.

Precautions

This medication should not be used in certain patients. For example, it should be avoided in patients with allergies to this drug or its ingredients, patients with cardiogenic shock, those with conduction problems in the heart, pulmonary heart disease, patients with metabolic acidosis due to diabetes, etc. Additionally, it is not recommended for women who are pregnant or breastfeeding, or for patients with respiratory diseases such as asthma or chronic obstructive pulmonary disease. Patients with genetic lactose intolerance should not take this medication. This drug should be used cautiously in patients with diabetes, those with a significant history of allergies, patients with hypotension, those with impaired kidney or liver function, and elderly patients. Blood pressure, heart rate, kidney and liver function should be regularly monitored under the instructions of a physician during treatment. Side effects such as dizziness, fatigue, headache, decreased heart rate, hypotension, respiratory distress, and skin rash may occur. If symptoms worsen, consult a physician immediately. Additionally, stopping this medication suddenly can worsen cardiac symptoms, so any discontinuation or dose adjustment must be done gradually and under the guidance of a physician. This medication may interact with other drugs, so if you are taking other medications such as antihypertensives, antidiabetics, antidepressants, analgesics, and anesthetics, be sure to inform your doctor or pharmacist. If pregnant or breastfeeding, this medication should not be taken as it may affect the fetus or newborn. The safety and effectiveness for children and adolescents have not been sufficiently established, so use is not recommended. Elderly patients may have decreased liver function and should start at a low dose and be closely monitored. In cases of overdose, severe hypotension, decreased heart rate, decreased cardiac function, shock, and respiratory distress may occur, necessitating immediate medical attention and emergency treatment. This drug may discolor when exposed to light, so it should be stored in a container that prevents light exposure and kept out of reach of children.

Side effects

  • Dizziness
  • headache
  • fatigue
  • weakness
  • hallucination
  • confusion
  • depression
  • sleep disturbance
  • nightmare
  • psychosis
Show 56 more
  • severe bradycardia
  • shock
  • complete atrioventricular block
  • heart failure
  • cardiac arrest
  • hypotension
  • loss of consciousness
  • cold extremities
  • edema
  • asystole
  • worsening of renal function
  • renal failure
  • increased airway resistance
  • nausea
  • diarrhea
  • abdominal pain
  • vomiting
  • constipation
  • hives
  • itching
  • lichenoid reaction
  • sweating
  • allergic rash
  • serum aminotransferase changes
  • thrombocytopenia
  • leukopenia
  • hypoglycemia
  • hyperglycemia
  • weight gain
  • increased blood cholesterol
  • bradycardia
  • hypotension
  • shortness of breath
  • angina
  • liver dysfunction
  • jaundice
  • limb pain
  • decreased tears
  • sensory disturbance
  • visual impairment
  • eye irritation
  • dry mouth
  • urination disorder
  • sexual dysfunction
  • allergic reaction
  • toxic epidermal necrolysis
  • Stevens-Johnson syndrome
  • blood pressure lowering
  • heart rate reduction
  • myocardial weakening
  • asystole
  • cardiogenic shock
  • respiratory distress
  • bronchospasm
  • consciousness disturbance
  • generalized seizure

Not everyone experiences these, and they can vary from person to person.

Storage

This medication is light-sensitive and should be stored in a container that does not allow light in. Additionally, it is recommended to store the medication at room temperature between 1°C and 30°C. This will help maintain the medication's effectiveness for a longer period.

Appearance and packaging

Appearance

Brownish-red round tablet

Package unit

90 tablets (10 tablets/PTP × 9)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.